Microbot Medical Inc (MBOT)
0.98
+0.05
(+5.41%)
USD |
NASDAQ |
Nov 22, 16:00
0.987
+0.01
(+0.71%)
After-Hours: 20:00
Microbot Medical Cash from Financing (Quarterly): 0.633M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.633M |
| June 30, 2024 | 2.074M |
| March 31, 2024 | 2.397M |
| December 31, 2023 | 0.00 |
| September 30, 2023 | -0.161M |
| June 30, 2023 | 6.719M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 4.324M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | -3.375M |
| December 31, 2019 | 27.21M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 9.562M |
| December 31, 2018 | -0.018M |
| September 30, 2018 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.397M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 9.54M |
| March 31, 2017 | 3.082M |
| December 31, 2016 | 2.179M |
| September 30, 2016 | 0.154M |
| June 30, 2016 | 0.75M |
| March 31, 2016 | 0.00 |
| December 31, 2015 | -20.39M |
| September 30, 2015 | -1.045M |
| June 30, 2015 | 23.68M |
| March 31, 2015 | -1.830M |
| December 31, 2014 | -0.9953M |
| September 30, 2014 | 21.29M |
| June 30, 2014 | -0.7171M |
| March 31, 2014 | 2.616M |
| December 31, 2013 | 16.77M |
| September 30, 2013 | 4.911M |
| June 30, 2013 | 13.01M |
| March 31, 2013 | 1.716M |
| December 31, 2012 | 5.606M |
| September 30, 2012 | 17.08M |
| June 30, 2012 | 2.403M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-3.375M
Minimum
Mar 2020
27.21M
Maximum
Dec 2019
2.655M
Average
--
Median
Jun 2020
Cash from Financing (Quarterly) Benchmarks
| Twist Bioscience Corp | 3.627M |
| Perspective Therapeutics Inc | 0.628M |
| Retractable Technologies Inc | -0.1343M |
| Xtant Medical Holdings Inc | 5.314M |
| Catheter Precision Inc | 4.02M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.759M |
| Cash from Investing (Quarterly) | 0.14M |
| Free Cash Flow | -8.97M |
| Free Cash Flow Per Share (Quarterly) | -0.1675 |
| Free Cash Flow Yield | -63.99% |